Ankrah Paa Kwesi, Mensah Enock D, Dabie Kwabena, Mensah Caleb, Akangbe Benjamin, Essuman Jonathan
Division of Infectious Diseases, Duke University, Durham, USA.
Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, USA.
Cureus. 2024 Mar 4;16(3):e55495. doi: 10.7759/cureus.55495. eCollection 2024 Mar.
Aging is inevitable, but the lifespan (duration of life) and healthspan (healthy aging) vary greatly among individuals and across species. Unlocking the secrets behind these differences has captivated scientific curiosity for ages. This review presents relevant recent advances in genetics and cell biology that are shedding new light by untangling how subtle changes in conserved genes, pathways, and epigenetic factors influence organismal senescence and associated declines. Biogerontology is a complex and rapidly growing field aimed at elucidating genetic modifications that extend lifespan and healthspan. This review explores gerontogenes, genes influencing lifespan and healthspan across species. Though subtle differences exist, long-lived individuals such as centenarians demonstrate extended healthspans, and numerous studies confirm the heritability of longevity/healthspan genes. Importantly, genes and gerontogenes are directly and indirectly involved in DNA repair, insulin/IGF-1 and mTOR signaling pathways, long non-coding RNAs, sirtuins, and heat shock proteins. The complex interactions between genetics and epigenetics are teased apart. While more research into optimizing healthspan is needed, conserved gerontogenes offer synergistic potential to forestall aging and age-related diseases. Understanding complex longevity genetics brings closer the goal of extending not only lifespan but quality years of life. The primary aim of human Biogerontology is to enhance lifespan and healthspan, but the question remains: are current genetic modifications effectively promoting healthy aging? This article collates the advancements in gerontogenes that enhance lifespan and improve healthspan alongside their potential challenges.
衰老不可避免,但寿命(生命持续时间)和健康寿命(健康衰老)在个体之间以及物种之间差异巨大。揭开这些差异背后的秘密长久以来一直激发着科学探索的好奇心。本综述介绍了遗传学和细胞生物学领域的相关最新进展,这些进展通过梳理保守基因、信号通路和表观遗传因子的细微变化如何影响机体衰老及相关衰退,为我们带来了新的认识。生物老年学是一个复杂且快速发展的领域,旨在阐明延长寿命和健康寿命的基因修饰。本综述探讨了老年基因,即影响不同物种寿命和健康寿命的基因。尽管存在细微差异,但像百岁老人这样的长寿个体展现出更长的健康寿命,并且大量研究证实了长寿/健康寿命基因的遗传性。重要的是,基因和老年基因直接或间接参与DNA修复、胰岛素/胰岛素样生长因子-1和雷帕霉素靶蛋白信号通路、长链非编码RNA、沉默调节蛋白和热休克蛋白。遗传学与表观遗传学之间的复杂相互作用也得以剖析。虽然还需要更多关于优化健康寿命的研究,但保守的老年基因具有协同作用的潜力,可延缓衰老及与年龄相关的疾病。了解复杂的长寿遗传学使我们更接近不仅延长寿命,而且延长高质量生活年限的目标。人类生物老年学的主要目标是延长寿命和健康寿命,但问题仍然存在:当前的基因修饰是否有效地促进了健康衰老?本文整理了在延长寿命和改善健康寿命方面的老年基因研究进展及其潜在挑战。